SCI & TECH● LOWSep 8 · Sep 8, 2026, 10:57 AM
Roivant climbs on mid-stage trial win for lung disease candidate
Seeking Alpha Tech · global
Roivant's stock rose following a successful mid-stage clinical trial for its lung disease candidate. This positive trial outcome represents a potential advancement in medical treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH10m agoArchaeologists are uncovering the meaning of a unique rock art siteNew ScientistSCI & TECH25m agoTelix and Ekalia to Collaborate on Astatine - 211 Production in the U . S . australiannews.net · AustraliaSCI & TECH45m agoNigeria joins league of nations in global measurement pactVanguard NigeriaSCI & TECH1h agoAfter a decade of disruption, Pattanam needs a renewed visionThe Hindu